Susana Puig

Sobre mi

Publicacions destacades

• Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test

  Autors:

  Jarell, Abel; Gastman, Brian R; Hsueh, Eddy C; Podlipnik, Sebastian; Covington, Kyle R;

  (...)

  Quick, Ann P; Martin, Brian J; Kurley, Sarah J; Goldberg, Matthew S; Puig, Susana.

  Veure llistat complet d'autors

  Referència: Journal Of The American Academy Of Dermatology 2022.

• Synchronous primary cutaneous melanomas: a descriptive study of their clinical features, histology, genetic background of the patients and clinical outcomes

  Autors:

  Antunez-Lay, A; Podlipnik, S; Carrera, C; Potrony, M; Tell-Marti, G;

  Badenas, C; Puig-Butille, J A; Espinosa, N; Puig, S; Malvehy, J.

  Referència: Journal Of The European Academy Of Dermatology And Venereology 2022.

• Common genetic variants associated with melanoma risk or naevus count in wild-type MC1R melanoma patients

  Autors:

  Calbet-Llopart, Neus; Combalia, Marc; Kiroglu, Anil; Potrony, Miriam; Tell-Marti, Gemma;

  (...)

  Podlipnik, Sebastian; Carrera, Cristina; Puig, Susana; Malvehy, Josep; Puig-Butille, Joan Anton.

  Veure llistat complet d'autors

  Referència: British Journal Of Dermatology 2022.

• Dermatoscopic and clinical features of congenital or congenital-type nail matrix nevi: A multicenter prospective cohort study by the International Dermoscopy Society

  Autors:

  Pham, Felix; Boespflug, Amelie; Duru, Gerard; Phan, Alice; Poulalhon, Nicolas;

  (...)

  Robert, Caroline; Schopf, Thomas R; Scope, Alon; Dalle, Stephane; Thomas, Luc.

  Veure llistat complet d'autors

  Referència: Journal Of The American Academy Of Dermatology 2022.

• Validation of artificial intelligence prediction models for skin cancer diagnosis using dermoscopy images: the 2019 International Skin Imaging Collaboration Grand Challenge

  Autors:

  Combalia, Marc; Codella, Noel; Rotemberg, Veronica; Carrera, Cristina; Dusza, Stephen;

  (...)

  Rinner, Christoph; Tschandl, Philipp; Weber, Jochen; Halpern, Allan; Malvehy, Josep.

  Veure llistat complet d'autors

  Referència: Lancet Digital Health, The 2022.

• Cross-cohort gut microbiome associations with immune checkpoint inhibitor response in advanced melanoma

  Autors:

  Lee, Karla A; Thomas, Andrew Maltez; Bolte, Laura A; Bjork, Johannes R; de Ruijter, Laura Kist;

  (...)

  Bataille, Veronique; Hospers, Geke A P; Spector, Tim D; Weersma, Rinse K; Segata, Nicola.

  Veure llistat complet d'autors

  Referència: Nature Medicine 2022.

• Using a 31-Gene Expression Profile Test to Stratify Patients with Stage I-II Cutaneous Melanoma According to Recurrence Risk: Update to a Prospective, Multicenter Study

  Autors:

  Podlipnik, Sebastian; Boada, Aram; Lopez-Estebaranz, Jose L; Martin-Gonzalez, Manuel M; Redondo, Pedro;

  (...)

  Quick, Ann P; Bailey, Christine N; Kurley, Sarah J; Cook, Robert W; Puig, Susana.

  Veure llistat complet d'autors

  Referència: Cancers 2022.

Projectes destacats

• Medicina personalizada en melanoma: biomarcadores de pronóstico y respuesta a inmunoterapia, y su relación con la dieta y ejercicio físico

  Investigador/a principal: Susana Puig

  Finançador: Instituto de Salud Carlos III

  Codi: PI22/01457

  Durada: 01/01/2023 - 31/12/2025

• MELCAYA - Novel health care strategies for melanoma in children, adolescents and young adults

  Investigador/a principal: Susana Puig Sarda

  Finançador: European Commission

  Codi: CE_HE_CANCER21_RIA

  Durada: 01/12/2022 - 30/11/2026

  Web: https://www.melcaya.eu/

• Monitoring multidimensional aspects of QUAlity of Life after cancer ImmunoTherapy - an Open smart digital Platform for personalized prevention and patient management.

  Investigador/a principal: Susana Puig Sarda

  Finançador: European Commission

  Codi: CE_H2020-SC1_19_1s24

  Durada: 01/01/2020 - 30/06/2024

• Implicación del perfil inmunológico específico cutáneo determinado en sangre periférica en el pronóstico y respuesta a tratamiento del melanoma

  Investigador/a principal: Susana Puig Sarda

  Finançador: Instituto de Salud Carlos III

  Codi: PI18/00419

  Durada: 02/01/2019 - 31/12/2021

• Vías de diseminación mestastásica en distintos subtipos del melanoma maligno: nuevos biomarcadores tumorales y dianas terapeuticas

  Investigador/a principal: Josep Malvehy Guilera

  Finançador: Asociación Española Contra el Cáncer

  Codi: GCB15152978SOEN

  Durada: 01/07/2015 - 31/12/2020